CGON

COM:CGONCOLOGY

CG Oncology

  • Stock

Last Close

32.24

21/11 14:59

Market Cap

2.19B

Beta: -

Volume Today

96.63K

Avg: -

CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus...Show More

peer of

investor of